Welcome to our dedicated page for Smoore Intl Hldg news (Ticker: SMHRY), a resource for investors and traders seeking the latest updates and insights on Smoore Intl Hldg stock.
SMOORE INTL HLDGS ADR (SMHRY) is a global leader in atomization technology solutions, with a focus on innovation and excellence in the vaping industry. SMOORE, along with its subsidiary VAPORESSO, has garnered over 130 international awards for its cutting-edge products, such as XROS 3, LUXE X, ARMOUR, and COSS, showcasing their commitment to quality and technology. In 2023, VAPORESSO received recognition from esteemed organizations and media outlets, solidifying its position as a pioneer in open-system vaping devices. The company's strategic collaborations, like SMOORE ODM+, and participation in premier trade shows like Total Product Expo (TPE24), highlight its dedication to pushing industry boundaries and delivering top-notch vaping experiences.
SMOORE, a leader in vaping technology, reported a 2021 annual revenue of RMB13.75 billion, marking a 37.4% year-on-year increase. The company boasts a 22.8% market share in global vaping device manufacturing. SMOORE aims for carbon neutrality by 2050 and has invested over RMB670 million in R&D, increasing expenditures by 59.7%. Corporate client sales grew to RMB12.59 billion, with over 70% of revenue from overseas. The company continues to innovate, introducing new products such as FEELM Air.
SMOORE, a leader in vaping technology, has launched the world's first E&L testing laboratory for the vaping industry, enhancing product safety through advanced analytical testing. Established in late 2021, the lab performs qualitative and quantitative assessments on electronic atomization components, ensuring compliance with PMTA safety requirements. In collaboration with SMITHERS, this initiative positions SMOORE at the forefront of e-cigarette safety as global regulators tighten standards. The lab's capabilities extend to healthcare applications, further expanding SMOORE's innovation potential.
The press release highlights SMOORE as China’s first company to establish a TPD-compliant risk assessment laboratory for vaping products. This facility, operational since early 2021, aims to help brands meet EU regulatory requirements, completing 52 tests for various vape brands. The EU vaping market represents a substantial opportunity, projected to grow to USD 5.58 billion with a CAGR of 13.17% over the next six years. SMOORE adheres to stringent safety guidelines, enhancing its competitive position.
SMOORE, a leader in vaping technology, has collaborated with RELX on clinical research to assess the health effects of vaping, including its impact on the respiratory and cardiovascular systems. This research, registered in February 2022, is part of broader efforts to establish industry standards and safety protocols. The company also introduced the FEELM Air vape pod with an 80% improvement in harm reduction. As vape regulations tighten in China, SMOORE continues to focus on R&D to enhance product safety and effectiveness. SMOORE holds an 18.9% market share in the global vaping sector.
SMOORE, the world's largest vaping manufacturer, has launched the FEELM Air, a groundbreaking ceramic coil vape pod, in London. This device incorporates an Ultra-slim Bionic Film Ceramic Coil with seven key advancements, enhancing flavor, reliability, and user experience. Notably, it boasts an 80% reduction in harm compared to earlier models and features innovative technologies for improved flavor and energy efficiency. The launch included a brand refresh emphasizing sensory experiences. SMOORE, holding 18.9% of the global market, aims to lead a new revolution in vaping.
Bluehole New Consumption has reported significant updates in China’s vaping regulations, as the State Tobacco Monopoly Administration released new draft rules governing e-cigarettes. The regulations aim to eliminate uncertainties in the vaping industry and promote sustainable development. China's e-cigarette market has seen exponential growth, reaching RMB 8.38 billion in 2020. With over 300 million smokers in China, the new standards will ensure safety and reliability, ultimately benefiting leading companies like SMOORE, which is poised to introduce advanced technology.
China’s vaping industry is seeing regulatory advancements, as health regulators in the UK, US, and Malaysia are increasingly accepting e-cigarettes. On October 29, 2021, the UK announced plans for NHS prescription of e-cigarettes, while Malaysia imposed excise duties on nicotine products to promote compliance with safety standards. The US FDA granted marketing orders for Vuse Solo, marking a significant step for authorized e-cigarettes. This regulatory trend suggests a more standardized and competitive vaping market, benefiting leading companies like BAT and SMOORE.
On October 12, 2021, the FDA authorized the marketing of Vuse Solo, the first vaping product to receive approval through the Premarket Tobacco Product Application (PMTA). This milestone signifies FDA’s acceptance of vaping's potential public health benefits. However, other flavor variants submitted by R.J. Reynolds were denied, reflecting the agency's focus on preventing youth nicotine addiction. With a market share exceeding 26% in key markets, Vuse is positioned as a leading vapor brand, expected to maintain growth due to its first-mover advantage and innovative ceramic coil technology.
SMOORE, a leader in vaping technology, held the 2021 UK Media Day at Silverstone Circuit, emphasizing its flagship brand, FEELM. Chief Scientist Dr. Shi Zhiqiang highlighted FEELM's innovations in atomization technology, pivotal for vape performance. Since its global launch in 2016, FEELM has established itself as a key player, boasting an 18.9% global market share in 2020. With advanced production techniques and a commitment to quality, the brand aims to enhance the vaping experience and explore healthcare applications.